The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth.

Nozawa F., Itami A., Saruc M., Kim M., Standop J., Picha K., ...More

Pancreas, vol.29, pp.45-52, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29
  • Publication Date: 2004
  • Doi Number: 10.1097/00006676-200407000-00055
  • Journal Name: Pancreas
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.45-52
  • Keywords: TRAIL/Apo2L, genistein, apoptosis, pancreatic cancer, TRAIL-INDUCED APOPTOSIS, IN-VIVO, CELL-LINE, FACTOR RECEPTOR, AKT, CHEMOTHERAPY, CARCINOMA, DEATH, OVEREXPRESSION, INDUCTION
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No